Q2 24 Summary Results (GAAP) • Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%) • GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02) • Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49 • Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10) • Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607 (Address of principal executive offices) (Zip Code) (844) 848-0137 (Registrant's telephone number, including area code) Indicate by check mark whether the re ...

Dentsply International (XRAY) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -2%. A quarter ago, it was expected that this dental products manufacturer would post earnings of $0.42 per share when it actually produced earnings of $0.42, delivering no surprise. Over the last four quar ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------|-------|-------|-------|-------|-------|-------|-------|-------| | (in millions) | | 2024 | | 2023 | | 2024 | | 2023 | | Connected Technology Solutions | $ | 3 | $ | 26 | $ | 5 | $ | 32 | | Essential Dental Solutions | | 125 | | 125 | | 240 | | 250 | | Orthodontic and Implant Solutions | | 42 | | 49 | | 84 | | 98 | | Wellspect Healthcare | | 24 | | 21 | | 47 | | 39 | | Segment adjusted operating income | | 194 | | ...

Q2 24 Summary Results (GAAP) Q2 24 Summary Results (Non-GAAP)[1] Q2 24 Segment Results | --- | --- | --- | --- | |--------------------------------------------------------|-------|--------|--------| | (in millions, except per share amount and percentages) | Q2 24 | Q2 23 | YoY | | Net Sales | $984 | $1,028 | (4.2%) | | Organic Sales Growth % | | | (2.3%) | | Adjusted EBITDA | $173 | $185 | (5.9%) | | Adjusted EBITDA Margin | 17.5% | 17.8% | | | Adjusted EPS | $0.49 | $0.51 | (4.0%) | Q2 24 Geographic Results ...

In the first quarter of 2024, XRAY's CTS segment declined significantly and the company expects further decline in the segment for the upcoming quarters as well. However, management expects to witness some improvements in the latter half of the year compared with the first half. The CAD/CAM segment is likely to have witnessed growth in the to-be-reported quarter on the back of increasing demand. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. McKesson (MCK) has an Earnings E ...

Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Brazil Dental Prosthetics Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Crowns and Bridges, Inlays and Onlays, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the Brazilian dental prosthetics market was valued at more than $10.2 billion. This market is projected to grow at a compound annual growth rate (CAGR) of 5.2%, reaching nearly $14.7 billion over the forecast period. The comprehensive report on Br ...

CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, July 31, 2024, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be ...

SAN DIEGO, June 17, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY). On August 01, 2023, an amended complaint was filed and on October 10, 2023, the defendants filed their motion to dismiss the amended complaint. CONTACT: SOURCE Shareholders Foundation, Inc. On June 02, 2022, an investor inNASDAQ: XRAY shares filed a lawsuit against DENTSPLY SIRONA Inc. The plaintiff alleged that ...

About Dentsply Sirona Investors: Andrea Daley Vice President, Investor Relations +1-704-591-8631 InvestorRelations@dentsplysirona.com CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions. Prior to this announcement, the Company was scheduled to participate on June 13, 2024, at 8:00 ...